SEEDPG
ABBV icon

S.E.E.D. Planning Group’s AbbVie ABBV Stock Holding History

S.E.E.D. Planning Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,230
Closed -$495K – 84
2022
Q2 		$495K Hold
3,230
– – 0.22% 52
2022
Q1 		$524K Hold
3,230
– – 0.22% 54
2021
Q4 		$437K Hold
3,230
– – 0.19% 56
2021
Q3 		$348K Buy
3,230
+900
+39% +$103K 0.16% 60
2021
Q2 		$262K Buy
2,330
+100
+4% +$11.3K 0.13% 69
2021
Q1 		$241K Hold
2,230
– – 0.13% 68
2020
Q4 		$239K Buy
+2,230
New +$214K 0.14% 62

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

S.E.E.D. Planning Group's ABBV Position: Q3 2022 in Review

S.E.E.D. Planning Group sold out of AbbVie (ABBV) in Q3 2022, closing a stake of 3,230 shares — an estimated $495K sold.

S.E.E.D. Planning Group first reported a position in ABBV in Q4 2020 and held it in 7 quarters. The position peaked at $524K in Q1 2022. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • S.E.E.D. Planning Group reported no remaining AbbVie position as of Q3 2022 after selling out during the quarter.
  • S.E.E.D. Planning Group sold 3,230 AbbVie shares in Q3 2022, an estimated $495K.
  • S.E.E.D. Planning Group first reported a position in AbbVie in Q4 2020 and held it in 7 quarters.
  • S.E.E.D. Planning Group's AbbVie position peaked at $524K in Q1 2022.
  • 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on S.E.E.D. Planning Group's 13F filing for Q3 2022, filed 20 Oct 2022.